Drug-induced granulomatous interstitial nephritis in a patient with ankylosing spondylitis during therapy with adalimumab

American Journal of Kidney Diseases

Volumn 56, Issue 6, 2010, Pages

  Korsten, Peter ^a,c   Sweiss, Nadera J ^b   Nagorsnik, Ulf ^a   Niewold, Timothy B ^b   Grne, Hermann Josef ^c   Gross, Oliver ^a   Mller, Gerhard A ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b UNIVERSITY OF CHICAGO   (United States)

^c DKFZ Heidelberg ^*  (Germany)

Author keywords

Ankylosing spondylitis; Granulomatous interstitial nephritis; Sarcoidosis; Tumor necrosis factor (TNF ) inhibitors

Indexed keywords

ADALIMUMAB; CREATININE; HLA B27 ANTIGEN; IBUPROFEN; INFLIXIMAB; PREDNISOLONE; RAMIPRIL; SALAZOSULFAPYRIDINE;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; BLOOD PRESSURE MEASUREMENT; CASE REPORT; CREATININE BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; EYE EXAMINATION; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GRANULOMATOUS INTERSTITIAL NEPHRITIS; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; KNEE PAIN; LOW BACK PAIN; PHLEBITIS; PHYSICAL EXAMINATION; RENOGRAPHY; SACROILIITIS; SARCOIDOSIS; THORAX RADIOGRAPHY; TREATMENT DURATION; UVEITIS;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; HUMANS; MALE; NEPHRITIS, INTERSTITIAL; SPONDYLITIS, ANKYLOSING; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78649443776     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2010.08.019     Document Type: Article

References (37)

1. N.J. Sweiss, and R.P. Baughman Tumor necrosis factor inhibition in the treatment of refractory sarcoidosis: slaying the dragon? J Rheumatol 34 11 2007 2129 2131
2. N.J. Sweiss, J. Curran, and R.P. Baughman Sarcoidosis, role of tumor necrosis factor inhibitors and other biologic agents, past, present, and future concepts Clin Dermatol 25 3 2007 341 346
3. M. Ramos-Casals, A. Roberto Perez, C. Diaz-Lagares, M.J. Cuadrado, and M.A. Khamashta Autoimmune diseases induced by biological agents: a double-edged sword? Autoimmun Rev 9 3 2010 188 193
4. Toussirot E, Pertuiset E. [TNFalpha blocking agents and sarcoidosis: an update.] [published online ahead of print May 24, 2010]. Rev Med Interne.
5. National Kidney Foundation K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: evaluation, classification, and stratification Am J Kidney Dis 39 2 suppl 1 2002 S1 S266
6. U. Costabel, S. Ohshimo, and J. Guzman Diagnosis of sarcoidosis Curr Opin Pulm Med 14 5 2008 455 461
7. J.E. Tong, D.N. Howell, and J.W. Foreman Drug-induced granulomatous interstitial nephritis in a pediatric patient Pediatr Nephrol 22 2 2007 306 309
8. A. Namias, R. Bhalotra, and M. Donowitz Reversible sulfasalazine-induced granulomatous hepatitis J Clin Gastroenterol 3 2 1981 193 198
9. V.H. Thomassen, T. Ring, J. Thaarup, and K. Baggesen Tubulointerstitial nephritis and uveitis (TINU) syndrome: a case report and review of the literature Acta Ophthalmol 87 6 2009 676 679
10. C.I. Daien, A. Monnier, and P. Claudepierre Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases Rheumatology (Oxford) 48 8 2009 883 886
11. G.H. Louie, P. Chitkara, and M.M. Ward Relapse of sarcoidosis upon treatment with etanercept Ann Rheum Dis 67 6 2008 896 898
12. C. Bachmeyer, L. Blum, B. Petitjean, F. Kemiche, and E. Pertuiset Granulomatous tattoo reaction in a patient treated with etanercept J Eur Acad Dermatol Venereol 21 4 2007 550 552
13. M.A. Gonzalez-Lopez, R. Blanco, M.C. Gonzalez-Vela, H. Fernandez-Llaca, and V. Rodriguez-Valverde Development of sarcoidosis during etanercept therapy Arthritis Rheum 55 5 2006 817 820
14. P.J. Hashkes, and I. Shajrawi Sarcoid-related uveitis occurring during etanercept therapy Clin Exp Rheumatol 21 5 2003 645 646
15. K. Phillips, and M. Weinblatt Granulomatous lung disease occurring during etanercept treatment Arthritis Rheum 53 4 2005 618 620
16. R.E. Farah, and M.D. Shay Pulmonary sarcoidosis associated with etanercept therapy Pharmacotherapy 27 10 2007 1446 1448
17. K. Verschueren, E. Van Essche, P. Verschueren, V. Taelman, and R. Westhovens Development of sarcoidosis in etanercept-treated rheumatoid arthritis patients Clin Rheumatol 26 11 2007 1969 1971 (Pubitemid 47516989)
18. L. Peno-Green, G. Lluberas, T. Kingsley, and S. Brantley Lung injury linked to etanercept therapy Chest 122 5 2002 1858 1860
19. E. Toussirot, E. Pertuiset, B. Kantelip, and D. Wendling Sarcoidosis occuring during anti-TNF-alpha treatment for inflammatory rheumatic diseases: report of two cases Clin Exp Rheumatol 26 3 2008 471 475
20. M. Farah, A. Al Rashidi, D.A. Owen, E.M. Yoshida, and G.D. Reid Granulomatous hepatitis associated with etanercept therapy J Rheumatol 35 2 2008 349 351
21. A. Kudrin, E.R. Chilvers, and A. Ginawi Sarcoid-like granulomatous disease following etanercept treatment for RA J Rheumatol 34 3 2007 648 649
22. T. Ishiguro, N. Takayanagi, and K. Kurashima Development of sarcoidosis during etanercept therapy Intern Med 47 11 2008 1021 1025
23. R. Almodovar, M. Izquierdo, P. Zarco, F. Javier Quiros, R. Mazzucchelli, and B. Steen Pulmonary sarcoidosis in a patient with ankylosing spondylitis treated with infliximab Clin Exp Rheumatol 25 1 2007 99 101
24. S. Josse, N. Klemmer, S. Moreno-Swirc, V. Goeb, T. Lequerre, and O. Vittecoq Infliximab induced skin and pulmonary sarcoidosis in a rheumatoid arthritis patient Joint Bone Spine 76 6 2009 718 719
25. A. Massara, L. Cavazzini, R. La Corte, and F. Trotta Comment on: Sarcoid-like granulomatosis in patients treated with tumour necrosis factor blockers: 10 cases Rheumatology (Oxford) 49 5 2010 1019 1021 author reply 1021-1022
26. F.D. O'Shea, T.K. Marras, and R.D. Inman Pulmonary sarcoidosis developing during infliximab therapy Arthritis Rheum 55 6 2006 978 981
27. F. Dhaille, V. Viseux, and A. Caudron Cutaneous sarcoidosis occurring during anti-TNF-alpha treatment: report of two cases Dermatology 220 3 2010 234 237
28. G. Sturfelt, B. Christensson, G. Bynke, and T. Saxne Neurosarcoidosis in a patient with rheumatoid arthritis during treatment with infliximab J Rheumatol 34 11 2007 2313 2314 (Pubitemid 350076897)
29. A.K. Palucka, J.P. Blanck, L. Bennett, V. Pascual, and J. Banchereau Cross-regulation of TNF and IFN-alpha in autoimmune diseases Proc Natl Acad Sci U S A 102 9 2005 3372 3377
30. C.P. Mavragani, T.B. Niewold, N.M. Moutsopoulos, S.R. Pillemer, S.M. Wahl, and M.K. Crow Augmented interferon-alpha pathway activation in patients with Sjogren's syndrome treated with etanercept Arthritis Rheum 56 12 2007 3995 4004
31. Y. Ioannou, and D.A. Isenberg Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy Arthritis Rheum 43 7 2000 1431 1442
32. S.N. Kariuki, and T.B. Niewold Genetic regulation of serum cytokines in systemic lupus erythematosus Transl Res 155 3 2010 109 117
33. S.N. Kariuki, K.A. Kirou, E.J. MacDermott, L. Barillas-Arias, M.K. Crow, and T.B. Niewold Cutting edge: autoimmune disease risk variant of STAT4 confers increased sensitivity to IFN-alpha in lupus patients in vivo J Immunol 182 1 2009 34 38
34. M. Mahevas, F.X. Lescure, and J.J. Boffa Renal sarcoidosis: clinical, laboratory, and histologic presentation and outcome in 47 patients Medicine (Baltimore) 88 2 2009 98 106
35. M.M. Ahmed, E. Mubashir, and N.R. Dossabhoy Isolated renal sarcoidosis: a rare presentation of a rare disease treated with infliximab Clin Rheumatol 26 8 2007 1346 1349
36. D. van der Stoep, G.J. Braunstahl, J. van Zeben, and J. Wouters Sarcoidosis during anti-tumor necrosis factor-alpha therapy: no relapse after rechallenge J Rheumatol 36 12 2009 2847 2848
37. J.P. Utz, A.H. Limper, and S. Kalra Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis Chest 124 1 2003 177 185